Blocknomi
Key Takeaways Shares of TEM climbed more than 11% Friday, reaching $50.95 Nature Medicine published validation study showing Tempus’s PRISM2 AI platform excels at cancer detection Short interest above 30%…
Related articles
-
Coinbase Wrapped XRP Expands DeFi Utility Through Doppler Finance on Base
Bitcoin.com Published 29.07.2026 23:32
-
Strategy Stock Price Target Cut To $215 By Maxim Group
Blocknomi Published 06.08.2026 09:58
-
BlackRock’s IBIT accounted for 90% of a $225 million Bitcoin ETF reversal after a seven-day buying streak
CryptoSlate Published 24.07.2026 17:45
-
Bessent’s top crypto adviser Tyler Williams exits US Treasury: Report
Cointelegraph Published 03.08.2026 20:29
-
Kalshi CEO Blames Gambling Lobby for New York Lawsuit
Blocknomi Published 04.08.2026 10:14
-
Paid in DOGE: Dogecoin Co-Founder Shares Ultimate Crypto Experience
U.Today Published 28.07.2026 13:30
-
CLARITY Act Faces New Senate Threat Over Trump Crypto Gains
Bitcoin.com Published 03.08.2026 01:30
-
What is a DAO? Decentralized governance explained
Crypto.News Published 31.07.2026 08:21